FDA Approved: ZARXIO — Supplemental Application (Sandoz Inc.)

View source ↗

Summary

The FDA approved Sandoz's supplemental application for Zarxio (filgrastim-sndz), granting biosimilar approval for the same indications as the reference product,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Neutropenia Due to Chemotherapy

Drugs mentioned

• ZARXIO (FILGRASTIM-SNDZ)

Snippet

SUPPL AP for ZARXIO (FILGRASTIM-SNDZ)